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Background The role of Th17 cells in the pathogenesis of 
human autoimmune diseases is elusive. To gain insights into 
the role of Th17 cells in human autoimmune diseases, the 
authors analysed Th17 cells in patients with prototypic auto-
immune diseases such as rheumatoid arthritis (RA) and psori-
atic arthritis (PsA).
Methods and Results Th17 cells were analysed in well-defi ned 
homogeneous cohorts of patients: treatment-naive patients 
with active early RA (n=6; disease duration 2.8 months; dis-
ease activity score 28 (DAS28) 5.0) and PsA (n=9; disease dura-
tion 2.3 months), and patients with established RA responding 
or not responding to therapy with methotrexate/adalimumab 
(n=1; mean disease duration 68 months). Healthy individuals 
and patients with osteoarthritis were used as control cohorts. 
Th17 cell frequencies and IL17 production strongly correlated 
with systemic disease activity at both the onset and the pro-
gression of the diseases. They were reduced to control levels 
in response to clinically effective treatment. Th17 cells were 
enriched in the joints, and increased frequencies of synovial 
Th17 cells expressed CCR4 and CCR6, indicative of selective 
migration of Th17 cells to the joints. The intrinsically ele-
vated expression of the master transcription factor for Th17 
cells, RORC, accompanied by biased Th17 cell development 
and a resistance of Th17 cells from the patients to natural 
02_ar-69_2(Suppl)-abstract.indd   69 2/17/2010   4:36:17 PM
 group.bmj.com on February 10, 2014 - Published by ard.bmj.comDownloaded from 
EWRR abstracts
Ann Rheum Dis 2010;69(Suppl 2):A1–A76A70
antagonists of their development (for example, interleukin 4 
and interferon γ) are suggestive of the underlying molecular 
mechanisms of uncontrolled Th17 activity in patients with 
autoimmune arthritides.
Conclusions These data offer intriguing insights into the 
mechanisms of autoimmune infl ammation, identify Th17 
cells as a central effector T cell in the pathophysiology of auto-
immune arthritides and provide the scientifi c basis for target-
ing Th17 cell functions in the treatment of RA and PsA.
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